Lifecore Biomedical, Inc.
Index- P/E- EPS (ttm)-2.84 Insider Own0.20% Shs Outstand29.63M Perf Week20.99%
Market Cap111.55M Forward P/E- EPS next Y-0.03 Insider Trans- Shs Float29.04M Perf Month-32.95%
Income-83.90M PEG- EPS next Q-0.06 Inst Own88.60% Short Float / Ratio1.83% / 0.63 Perf Quarter-45.37%
Sales182.90M P/S0.61 EPS this Y-560.00% Inst Trans-1.89% Short Interest0.53M Perf Half Y-57.54%
Book/sh2.50 P/B1.51 EPS next Y94.20% ROA-31.50% Target Price8.00 Perf Year-66.94%
Cash/sh0.23 P/C16.40 EPS next 5Y10.00% ROE-93.10% 52W Range1.52 - 11.95 Perf YTD-41.74%
Dividend- P/FCF- EPS past 5Y-51.30% ROI-22.70% 52W High-68.42% Beta1.16
Dividend %- Quick Ratio0.30 Sales past 5Y-16.90% Gross Margin21.10% 52W Low148.36% ATR0.52
Employees689 Current Ratio0.60 Sales Q/Q-10.80% Oper. Margin-41.20% RSI (14)43.57 Volatility9.88% 19.04%
OptionableYes Debt/Eq1.98 EPS Q/Q-392.70% Profit Margin-49.50% Rel Volume0.58 Prev Close3.79
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume839.21K Price3.78
Recom2.00 SMA20-8.31% SMA50-29.65% SMA200-53.76% Volume485,184 Change-0.40%
Mar-20-23Downgrade Stephens Overweight → Equal-Weight $11 → $2
Mar-17-23 09:53PM
Mar-16-23 04:24PM
Feb-16-23 08:22AM
04:30PM Loading…
Feb-07-23 04:30PM
Jan-12-23 08:01AM
Jan-11-23 04:35PM
Jan-09-23 04:05PM
Dec-28-22 12:17PM
Dec-23-22 07:29AM
Dec-08-22 05:26AM
Nov-25-22 04:50PM
Nov-17-22 01:17PM
Nov-15-22 08:30AM
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WYNNEFIELD PARTNERS SMALL CAP 10% OwnerNov 25Buy7.97345,2602,751,7221,972,853Jan 18 05:23 PM
WYNNEFIELD PARTNERS SMALL CAP 10% OwnerNov 25Buy7.97282,4862,251,4132,438,180Jan 18 05:23 PM